| Breakdown |
|---|
Income Statement |
| Total Revenue |
| Gross Profit |
| EBITDA |
| Net Income |
Balance Sheet |
| Total Assets |
| Cash, Cash Equivalents and Short-Term Investments |
| Total Debt |
| Total Liabilities |
| Stockholders Equity |
Cash Flow |
| Free Cash Flow |
| Operating Cash Flow |
| Investing Cash Flow |
| Financing Cash Flow |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| ― | ― | ― | ― | ― | ― | ― | |
80 Outperform | $2.25B | 9.72 | 9.90% | 3.68% | -1.76% | 32.44% | |
76 Outperform | $2.62B | 9.85 | 10.16% | 3.69% | 5.15% | 16.42% | |
75 Outperform | $2.22B | 22.44 | 6.39% | 1.69% | -5.72% | -3.86% | |
74 Outperform | $2.50B | 15.12 | 8.99% | ― | -0.37% | -20.30% | |
68 Neutral | $2.51B | 12.42 | 7.49% | 3.23% | -1.58% | 6.34% | |
68 Neutral | $2.44B | 11.13 | 10.87% | 2.35% | 17.95% | ― |
Trustmark Corporation has announced a new stock repurchase program effective January 1, 2026, allowing for the acquisition of up to $100 million of its common shares by December 31, 2026. This program replaces the previous one set to expire on December 31, 2025, and offers flexibility in purchasing shares based on market conditions, with no obligation on the number or value of shares repurchased.
On November 17, 2025, Trustmark Corporation announced an agreement to issue and sell $175 million of 6.00% Fixed-to-Floating Rate Subordinated Notes due 2035. The offering, underwritten by Keefe, Bruyette & Woods and Goldman Sachs, aims to raise approximately $173.1 million after underwriting discounts. The proceeds will be used to repay $125 million of existing notes due 2030 and for general corporate purposes. The issuance is expected to close on November 20, 2025, subject to customary conditions, and will impact Trustmark’s financial structure by refinancing existing debt and potentially improving liquidity.
Trustmark Corporation has released updated presentation materials for use in meetings with investors and analysts during the fourth quarter of 2025. The presentation outlines the company’s financial performance, growth opportunities, and market conditions, while cautioning stakeholders about potential risks and uncertainties that could impact future results. The materials emphasize Trustmark’s strategic initiatives and financial health, although they include unaudited figures and non-GAAP financial measures.